Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03712891
Recruitment Status : Recruiting
First Posted : October 19, 2018
Last Update Posted : June 4, 2019
Sponsor:
Information provided by (Responsible Party):
Rachel Baker, TriHealth Inc.

Brief Summary:
The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Condition or disease Intervention/treatment Phase
PACU Length of Stay Postoperative Nausea Postoperative Vomiting Patient Satisfaction Dietary Supplement: Coffee Not Applicable

Detailed Description:
Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
Actual Study Start Date : October 25, 2018
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020

Arm Intervention/treatment
Experimental: Patients receiving coffee postoperatively
Patients who self-identify as coffee drinkers and receive coffee postoperatively
Dietary Supplement: Coffee
Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)

No Intervention: Patients not receiving coffee postoperatively
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively



Primary Outcome Measures :
  1. PACU length of stay [ Time Frame: 6 hours ]
    Post-anesthesia Care Unit length of stay



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria:

  1. 18 years old or older
  2. Admitted to Bethesda North Minimally Invasive Surgery Center
  3. Reports to consume at least one cup of coffee a day for at least 5 days in a week

Exclusion Criteria

  1. History of PONV
  2. Pre-existing cardiac arrhythmias
  3. History of seizure disorder
  4. Pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03712891


Contacts
Layout table for location contacts
Contact: Rachel Baker, PhD, RN 5135696191 Rachel_Baker2@trihealth.com

Locations
Layout table for location information
United States, Ohio
Bethesda North Hospital Recruiting
Cincinnati, Ohio, United States, 45242
Contact: Rachel Baker    513-569-6191    Rachel_Baker2@trihealth.com   
Sponsors and Collaborators
TriHealth Inc.
Investigators
Layout table for investigator information
Principal Investigator: Brandon Ballhaus, BSN, RN TriHealth Inc.

Layout table for additonal information
Responsible Party: Rachel Baker, Nurse Researcher, TriHealth Inc.
ClinicalTrials.gov Identifier: NCT03712891     History of Changes
Other Study ID Numbers: 18-050
First Posted: October 19, 2018    Key Record Dates
Last Update Posted: June 4, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Rachel Baker, TriHealth Inc.:
PACU length of stay
coffee

Additional relevant MeSH terms:
Layout table for MeSH terms
Vomiting
Postoperative Nausea and Vomiting
Signs and Symptoms, Digestive
Signs and Symptoms
Postoperative Complications
Pathologic Processes
Nausea